Researchers, healthcare experts working to develop COVD-19 vaccine as death toll surges
Scientists at Beth Israel Deaconess Medical Center are in the early stages of developing a vaccine to treat COVID-19.
Scientists at Beth Israel Deaconess Medical Center are in the early stages of developing a vaccine to treat COVID-19.
“The stunning epidemiology and clinical features of COVID-19, particularly the potential for explosive and asymptomatic spread, increase the chance that a vaccine may actually be required to end this epidemic,” said Dan Barouch. Read Article
BIOQUAL announces the development of programs for in-vivo testing of COVID-19 candidate vaccines. BIOQUAL’s efforts to develop animal models for COVID-19 began in February 2020 in collaboration with Dr. Dan Barouch at Beth Israel Deaconess Medical Center and the Ragon Institute, both affiliated with Harvard Medical School. Read More
Dr. Dan Barouch speaks with Lisa Mullins from WBUR about COVID-19 vaccine plans with Johnson & Johnson. Listen more
Clinical trials are set to start by September, and if all goes well, it could be ready for emergency use early next year. Read Article
“The industry in Massachusetts is going to the mat to fight this thing.” Read Article
“And, logically, the larger amount of virus should trigger more severe disease by prompting a brisker inflammatory response. But that is still speculative. The relationship between initial viral dose and severity remains to be seen.”- Dr. Dan Barouch. Read more
Dr. Katy Stephenson speaks to NBC Boston about leading two clinical trials for a treatment for COVID-19 patients. See more
Pre-conference Community HIV Cure Research Workshop outlines the results. Read Article

3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu
[DISPLAY_ULTIMATE_SOCIAL_ICONS]
